| 000 | 01601 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516191049.0 | ||
| 264 | 0 | _c20141124 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1099-1557 | ||
| 024 | 7 |
_a10.1002/pds.3562 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSumi, Eriko | |
| 245 | 0 | 0 |
_aThe increase in prescriptions of bisphosphonates and the incidence proportion of osteonecrosis of the jaw after risk communication activities in Japan: a hospital-based cohort study. _h[electronic resource] |
| 260 |
_bPharmacoepidemiology and drug safety _cApr 2014 |
||
| 300 |
_a398-405 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdverse Drug Reaction Reporting Systems _xstatistics & numerical data |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xepidemiology |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCommunication |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Industry _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk |
| 700 | 1 | _aYamazaki, Toru | |
| 700 | 1 | _aTanaka, Shiro | |
| 700 | 1 | _aYamamoto, Keiichi | |
| 700 | 1 | _aNakayama, Takeo | |
| 700 | 1 | _aBessho, Kazuhisa | |
| 700 | 1 | _aYokode, Masayuki | |
| 773 | 0 |
_tPharmacoepidemiology and drug safety _gvol. 23 _gno. 4 _gp. 398-405 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pds.3562 _zAvailable from publisher's website |
| 999 |
_c23425909 _d23425909 |
||